Home Home    Branches    Join/Renew    CBA PracticeLink    Contact    Français       

 CBA.org Home
About Advocacy Events Interest Areas
Membership Prof. Develop. Publications Public/Media Member Resources
 
Quarterly Case Summaries

Quarterly Case Summaries
<< Back

April 1, 2009 to June 30, 2009
  1. Federal Court Offers Guidance On Best Practices in the Discovery Process of Intellectual Property Matters
    Eli Lilly Canada Inc. v. Sandoz Canada Inc. 2009 FC 345 (Tabib, Prothonotary)
     
  2. No Default Judgment Even Where No Defence
    Mövenpick-Holding v. Inter Management Services Limited 2009 FC 358 (Hugessen, J.)
     
  3. Discretionary Orders of Prothonotaries
    Apotex Inc. v. GlaxoSmithKline Inc., GlaxoSmithKline PLC, SmithKline Beecham Corporation, Doe Co. and all other entities unknown to the Plaintiff which are part of the GlaxoSmithKline group of companies 2009 FC 378 (Hughes, J.)
     
  4. Assessment of the Costs Associated with Experts in an NOC Proceeding
    Abbot Laboratories et al. v. Apotex Inc. et al. 2009 FC 399 (Parent, Assessment Officer)
     
  5. Significant Damages for Software Infringement in Default Judgment
    Microsoft Corporation v. PC Village Co. Ltd. 2009 FC 401 (Mandamin, J.)
     
  6. Motion for Production of Documents and Answers to Refused Questions Dismissed
    Simpson Strong-Tie Company Inc. v. Peak Innovations 2009 FC 392 (Mandamin, J.)
     
  7. Pleadings Motion in Patent Action Regarding Competition Act and Conspiracy Claims
    Multi Formulations Ltd. et al. v. Allmax Nutrition Inc. et. al. 2009 FC 416 (Aalto, Proth.)
     
  8. Federal Court Upholds the Prothonotary Orders During Examinations of Discovery
    Apotex Inc. v. H. Lundbeck A/S 2009 FC 419 (Beaudry, J.)
     
  9. Patent Did Not Claim Dosage Form As Required by PM(NOC) Regulations
    Bayer Inc. v. Canada (Health) 2009 FCA 133 (Pelletier, J.A.)
     
  10. Court Decides What Evidence to Admit Pursuant to Rule 289
    Weatherford Canada Ltd., Weatherford Canada Partnership, Edward Grenke and Grenco Industries Ltd. v. Corlac Inc., National-Oilwell Canada Ltd. and National Oilwell Incorporated 2009 FC 449 (Phelan, J.)
     
  11. Court of Appeal Finds That NOC Proceedings Cannot Grant Declarations of Vires
    Novopharm Limited v. Eli Lilly Canada Inc. 2009 FCA 138 (Décary, J.A., Linden, J.A. and Sexton, J.A.)
     
  12. Actual or Potential Damage required for a Statutory Passing-Off Claim
    PharmaCommunications Holdings Inc. v. Avencia International Inc. 2009 FCA 144 (Sexton, J.A.)
     
  13. Apotex 81 mg ASA Not Bio-Equivalent with Bayer ASA – Decision of Minister to Refuse to Issue a Notice of Compliance to Apotex Upheld by Federal Court
    Apotex Inc. v. Canada (Health) 2009 FC 452 (Phelan, J.)
     
  14. Motion For Summary Judgment for Breach of Copyright Dismissed
    Jules Jordan Video, Inc. and Ashley Gasper v. Alain Elmaleh et al. 2009 FC 488 (Harrington, J.)
     
  15. The High Cost of Particulars
    Abercrombie & Fitch Co. et al. v. Giant Tiger Stores Ltd. et al. 2009 FC 492 (Shore, J.)
     
  16. Invalidity Arguments May Be Raised on Appeal as a Defence to Patent Infringement Without a Cross-Appeal
    Johnson & Johnson Inc. v. Boston Scientific Ltd. 2009 FCA 155 (Sharlow, J.A.)
     
  17. Federal Court Recognizes Broad Discretion of Case Management Prothonotaries
    Varco Canada Limited v. Pason Systems Corp. 2009 FC 538 (Gibson, J.)
     
  18. L’accès à l’information
    Le Ministre de la Santé c. Merck Frosst Canada Ltée 2009 CAF 166 (Desjardins, J.)
     
  19. PM(NOC): Notice of Compliance Based Upon a Cross-Reference
    Sanofi Aventis Canada Inc. v. Canada (Health) and Laboratoire Riva Inc. 2009 FCA 169 (Linden, J.A., Sexton, J.A., Sharlow, J.A.)
     
  20. Court Allows Amended Statement of Claim to Include Patent Infringement Allegations Related to Export of Kits Outside Canadian Jurisdiction
    Varco Canada Limited, Varco L.P., Wildcat Services L.P., and Wildcat Services Canada, ULC v. Pason Systems Corp. and Pason Systems Inc. 2009 FC 555 (Mandamin, J.)
     
  21. Relevant Date Is Purchase Date
    The Minister of Health and The Attorney General of Canada v. Pharmascience Inc. 2009 FCA 183 (Linden, Sexton and Sharlow, JJ.A.)
     
  22. Court Refuses Motion for Extension of Time Pending Re-Examination
    Prenbec Equipment Inv. v. Timberblade Inc. 2009 FC 584 (Aalto, P.)
     
  23. Court of Appeal Finds That Claims Future Losses Inappropriate Under Section 8 of the PM(NOC) Regulations
    Merck Frosst Canada Ltd. v. Apotex Inc. 2009 FCA 187 (Noël, J.A., Layden-Stevenson, J.A. and Ryer, J.A.)
     
  24. An Allegation of Patent Infringement Must Set Out Facts Describing the Infringing Behaviour
    Heli Tech Services (Canada) Ltd., et al. v. Weyerhaeuser Company Ltd., et al. 2009 FC 592 (O’Reilly, J.)
     
  25. Failure to Preserve Business Records Contributes to Applicant Failing in Trade-marks Act Section 57 Expungement Application
    Kamsut, Inc. v. Jaymei Enterprises Inc. 2009 FC 627 (Lemieux, J.)
     
  26. Question of Law Too Complex for Summary Judgment
    Apotex Inc. v. Pfizer Canada Inc. et al. 2009 FC 631 (Kelen, J.)
     
  27. Two Costs Awards On Parallel Motions at the Federal Court of Appeal
    Simpson Strong-Tie Company, Inc. v. Peak Innovations Inc. 2009 FCA 202 (Preston, Assessment Officer)
     
  28. Minister Prohibited From Issuing NOC to Novopharm Until 2014
    Pfizer Canada Inc., et al v. Novopharm Limited, et al. 2009 FC 638 (Kelen, J.)
     
  29. PM(NOC) - Second Person Entitled to Its Day in Court
    Apotex Inc. v. Janssen-Ortho Inc. and Daiichi Sankyo Company Inc. 2009 FCA 212 (Nadon, J.A, Layden-Stevenson, J.A., Trudel, J.A.)
     
  Copyright © The Canadian Bar Association Privacy Policy    Terms of Use & Disclaimer